Timothy Chiang analyst CAPITAL ONE

Currently out of the existing stock ratings of Timothy Chiang, 58 are a BUY (92.06%), 3 are a HOLD (4.76%), 2 are a SELL (3.17%).

Timothy Chiang

Work Performance Price Targets & Ratings Chart

Analyst Timothy Chiang works at CAPITAL ONE with a stock forecast success ratio of 35.56% fulfilled within 183.36 days on average.

Timothy Chiang’s has documented 158 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on IRWD, Ironwood Pharmaceuticals at 02-Sep-2022.

Wall Street Analyst Timothy Chiang

Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 6/15/2018. The price target of $120 was fulfilled within 4 days with a profit of $17.71 (17.31%) receiving and performance score of 43.28.

Average potential price target upside

AMPH Amphastar P EYEN Eyenovia IRWD Ironwood Pharmaceuticals MYL Viatris RLYP Relypsa SGYP Synergy Pharmaceuticals SRPT Sarepta Therapeutics TEVA Teva Pharma Industries Ltd ADR VTRS Viatris IDYA Ideaya Biosciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

71

$29.09 (69.41%)

41

9 months 13 days ago

10/11 (90.91%)

$8.79 (14.13%)

337

Buy

70

$28.09 (67.02%)

44

9 months 27 days ago

2/3 (66.67%)

$8.35 (13.54%)

105

Hold

44

$2.09 (4.99%)

40

1 years 5 days ago

5/5 (100%)

$1.03 (2.40%)

86

Buy

33

$-25.16 (-43.26%)

24

2 years 2 months 11 days ago

3/3 (100%)

$-1.3 (-3.79%)

375

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Timothy Chiang?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?